• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

ASH 2020 Post Conference Perspectives: Updates in Multiple Myeloma

home / post-conference-perspectives / ash-2020-post-conference-perspectives-updates-in-multiple-myeloma

An expert in the field of multiple myeloma discusses key data releases from ASH 2020.

Joshua Richter, MD

EP. 1: Frontline Therapy in Multiple Myeloma

January 15th 2021

Joshua Richter, MD, discusses long-term follow up data findings for multiple myeloma and their implications on front-line therapy options for patients.

Watch

Joshua Richter, MD

EP. 2: Multiple Myeloma and Stem Cell Transplantation

January 22nd 2021

An expert in the management of multiple myeloma discusses new data released from the GRIFFIN trial as well as real-world evidence regarding frontline autologous stem cell transplantation.

Watch

Joshua Richter, MD

EP. 3: New Findings for Multiple Myeloma

January 22nd 2021

Joshua Richter, MD, provides an overview of new data from various trials presented at ASH 2020 regarding newly diagnosed patients with multiple myeloma.

Watch

Joshua Richter, MD

EP. 4: Future Directions in MM

January 29th 2021

An expert looks to the future directions in multiple myeloma and discusses upcoming advances in the field.

Watch

© 2025 MJH Life Sciences
AJMC®
All rights reserved.